| RS2096281827 |
GCK
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2096283005 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2096283096 |
GCK
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2096283124 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2096283216 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS2096283252 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS2096322019 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2096322248 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2096324530 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Permanent neonatal diabetes mellitus, Transient Neonatal Diabetes |
| RS2096324894 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Permanent neonatal diabetes mellitus |
| RS2096326746 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |
| RS2096362304 |
SCYL2
|
Health Risk |
Pathogenic |
Arthrogryposis multiplex congenita 4, neurogenic |
| RS2096371289 |
KCNMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Inborn genetic diseases |
| RS2096469777 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS2096481989 |
CAMK2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2096491549 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2096501278 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2096502530 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS2096504394 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2096546315 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |
| RS2096546757 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2096571200 |
SOX5
|
Health Risk |
Pathogenic |
— |
| RS2096571436 |
SOX5
|
Health Risk |
Pathogenic |
Lamb-Shaffer syndrome, Lamb-Shaffer syndrome |
| RS2096589470 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2096651533 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2096675479 |
KMT2C
|
Health Risk |
Pathogenic |
Neoplasm, Neoplasm |
| RS2096680726 |
CAMK2B
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2096699885 |
CAMK2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2096780961 |
CAMTA1
|
Health Risk |
Pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS2096781049 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS2096785311 |
CAMTA1
|
Health Risk |
Pathogenic |
— |
| RS2096785839 |
CAMTA1
|
Health Risk |
Pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS2096799052 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS2096801796 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS2096803850 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2096805941 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |
| RS2096823537 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy, Nemaline myopathy |
| RS2096854165 |
CAMTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Inborn genetic diseases |
| RS2096858510 |
DST
|
Health Risk |
Likely pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS2096866859 |
CAMTA1
|
Health Risk |
Likely pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS2096867388 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS2096893099 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2096895734 |
CAMTA1
|
Health Risk |
Pathogenic |
— |
| RS2097114467 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS2097209399 |
FLNB
|
Health Risk |
Likely pathogenic |
Atelosteogenesis type III, Atelosteogenesis type III |
| RS2097238148 |
FLNB
|
Health Risk |
Pathogenic |
— |
| RS2097257677 |
FLNB
|
Health Risk |
Likely pathogenic |
Atelosteogenesis type III, Atelosteogenesis type III |
| RS2097315324 |
FLNB
|
Health Risk |
Likely pathogenic |
— |
| RS2097315347 |
FLNB
|
Health Risk |
Pathogenic |
— |
| RS2097330797 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Connective tissue disorder |
| RS2097405328 |
DNASE1L3
|
Health Risk |
Likely pathogenic |
— |
| RS2097405382 |
DNASE1L3
|
Health Risk |
Likely pathogenic |
— |
| RS2097447247 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2097447453 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2097447725 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2097447879 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS2097449114 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2097452910 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2097453337 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2097481521 |
HTRA1
|
Health Risk |
Pathogenic |
HTRA1-related autosomal dominant cerebral small vessel disease, HTRA1-related autosomal dominant cerebral small vessel disease |
| RS2097481554 |
HTRA1
|
Health Risk |
Likely pathogenic |
CARASIL syndrome, CARASIL syndrome |
| RS2097494390 |
HTRA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2097516516 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2097534211 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS2097544341 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS2097548467 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2097550591 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2097567446 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |
| RS2097569950 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2097571378 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2097595072 |
SLC25A3
|
Health Risk |
Pathogenic |
Cardiomyopathy-hypotonia-lactic acidosis syndrome, Cardiomyopathy-hypotonia-lactic acidosis syndrome |
| RS2097597579 |
SLC25A3
|
Health Risk |
Pathogenic |
Cardiomyopathy-hypotonia-lactic acidosis syndrome, Cardiomyopathy-hypotonia-lactic acidosis syndrome |
| RS2097656766 |
TCF4
|
Health Risk |
Conflicting classifications of pathogenicity |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2097711696 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2097711830 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2097713802 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2097713999 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2097746958 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS2097747311 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2097747388 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS2097752909 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2097753394 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2097758221 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2097759896 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2097762566 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2097762588 |
DMD
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dystrophin, Neuromuscular disease caused by qualitative or quantitative defects of dystrophin |
| RS2097762928 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2097773424 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2097773972 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2097775442 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2097780990 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS2097844381 |
ALDH18A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive complex spastic paraplegia type 9B, Autosomal dominant spastic paraplegia type 9 |
| RS2097848034 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS2097849676 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS2097849830 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS2097850041 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2097850128 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2097882117 |
ALDH18A1
|
Health Risk |
Pathogenic |
— |
| RS2097886912 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2097887468 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |